Cargando…
Pharmacogenomics of Anti-platelet Therapy: How much evidence is enough for clinical implementation?
Pharmacogenomics, the study of the genomics of drug response and adverse effects, holds great promise for more effective individualized (personalized) medicine. Recent evidence supports a role of loss-of-function variants in the cytochrome P450 enzyme CYP2C19 as a determinant of clopidogrel response...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715315/ https://www.ncbi.nlm.nih.gov/pubmed/23697979 http://dx.doi.org/10.1038/jhg.2013.41 |